Good clin­i­cal prac­tices: FDA opens up­dat­ed ICH draft guid­ance for com­ments

The FDA this week re­leased new draft guid­ance that aims to mod­ern­ize clin­i­cal tri­als, with an up­date to the In­ter­na­tion­al Coun­cil for Har­mon­i­sa­tion’s (ICH) over­ar­ch­ing Good Clin­i­cal Prac­tice (GCP) guid­ance, last up­dat­ed in 2016.

GCPs are the in­ter­na­tion­al­ly-rec­og­nized eth­i­cal, sci­en­tif­ic and qual­i­ty stan­dards that hu­man tri­als should ad­here to, mak­ing any up­dates to the ICH guid­ance close­ly watched. In this lat­est round of re­forms, the guid­ance of­fers new rec­om­men­da­tions ap­plic­a­ble to a broad range of tri­als in­clud­ing those with in­no­v­a­tive de­sign el­e­ments or dig­i­tal health tech­nolo­gies.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER